The treatment landscape for patients with newly diagnosed multiple myeloma who are transplant‑ineligible continues to evolve, creating new opportunities—and challenges—for nursing practice. As new first‑line treatment options become available, nurses play a central role in safe administration, patient education, and ongoing monitoring over prolonged treatment durations. This CNSA webinar will explore contemporary nursing considerations in the management of transplant‑ineligible newly diagnosed multiple myeloma, alongside an innovative tele‑oncology case study from Toowoomba. The session will highlight how telehealth models can support drug administration closer to home, reduce pressure on high‑volume metropolitan hospitals, and improve access for patients in rural and regional areas. Through real‑world experience, attendees will gain insight into how tele‑oncology can improve patient travel burden while maintaining high‑quality, nurse‑led care.
Learning Objectives:
- Describe key nursing considerations in the management of patients with transplant‑ineligible newly diagnosed multiple myeloma.
- Recognise common administration, monitoring, and supportive care challenges associated with new first‑line therapies.
- Understand the role of specialist nurses in adverse event monitoring and patient education in long‑term myeloma treatment.
- Explore how tele‑oncology models can support drug administration and follow‑up in rural and regional settings.
In collaboration with
